Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 902219 Boston, MA

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$983,764
-$282,442 QoQ
Shares Held
707,745
-10.0% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 71% None 29%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $3,309,838,136 across 31 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $983,764 707,745
2025-12-31 $1,266,206 786,465
2025-09-30 $2,374,563 869,804
2025-06-30 $2,532,449 695,728
2025-03-31 $1,279,808 666,567
2024-12-31 $954,040 502,127
2024-09-30 $534,227 404,718
2022-03-31 $227,506 316,863
2021-12-31 $709,779 314,062
2021-06-30 $40,692,694 10,736,859
2021-03-31 $36,687,187 10,838,165
2020-12-31 $35,253,295 12,590,463
2020-09-30 $19,891,678 7,924,972
2020-06-30 $98,790,736 7,274,723
2020-03-31 $13,079,600 1,725,541